// App-Quantinova.ai

: Risk of Histological Transformation in Patients with Primary Refractory Follicular Lymphoma

Researchers

Presenter

  • Sara Alonso

Principal Investigators

  • Clementine Sarkozy

  • Marielle Wondergem

  • Attilio Guarini

  • Laura Magnano

  • Miguel Alcoceba

  • Martine E.D. Chamuleau

  • Sara Galimberti

  • Maria Gomes da Silva

  • Harald Holte

  • Emanuele Zucca

  • Silvia Montoto

  • Sandra Lockmer

  • Igor Aurer

  • Luigi Marcheselli

  • Dolores Caballero

  • Gilles Salles

  • Massimo Federico

Medical Centers

  • Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain

  • Department ChiMOMo, University of Modena and Reggio Emilia, Modena

  • Department of Nuclear Medicine, Hospices Civils de Lyon, CHU Lyon Sud, University Claude Bernard Lyon 1, Pierre Benite, France

  • Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands

  • hematology,Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico,Bari,Italy

  • Department of Pathology, Hospital Clinic de Barcelona, Barcelona, Spain

  • Department of Hematology, University Hospital of Salamanca, Salamanca, Spain

  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

  • Departamento de Hematologia,Instituto Português de Oncologia de Lisboa - IPO,Lisbon,Portugal

  • Oslo University Hospital, Oslo, Norway

  • Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland

  • Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Department of Respiratory Disease and Allergy, Karolinska University Hospital and Department of Medicine, Solna Karolinska Institutet, Stockholm, Sweden

  • Division of Hematology, Department of Internal Medicine, University Hospital Center Zagreb and Medical School University of Zagreb,

  • Fondazione Italiana Linfomi (FIL), Italian Lymphoma Foundation, Modena, Italy

  • Department of Hematology, Hospitalario Universitario de Salamanca (HUS/IBSAL) and CIBERONC, Salamanca, Spain

  • Univeristy of Modena and Reggio Emilia, Modena, Italy

Locations

  • Spain

  • Italy

  • France

  • Netherlands

  • Portugal

  • Norway

  • Switzerland

  • United Kingdom

  • Sweden

  • Croatia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Follicular lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved